MESOTHELIOMA, MALIGNANT
Clinical trials for MESOTHELIOMA, MALIGNANT explained in plain language.
Never miss a new study
Get alerted when new MESOTHELIOMA, MALIGNANT trials appear
Sign up with your email to follow new studies for MESOTHELIOMA, MALIGNANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First patients to receive experimental 'Living Drug' for tough cancers
Disease control Recruiting nowThis is a first-in-human safety study testing a single dose of an experimental cell therapy called SynKIR-110. It is for adults with advanced ovarian cancer, bile duct cancer, or mesothelioma that has come back after prior treatment. Doctors will collect a patient's own immune ce…
Matched conditions: MESOTHELIOMA, MALIGNANT
Phase: PHASE1 • Sponsor: Verismo Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New pill targets 'Hippo' pathway in Tough-to-Treat cancers
Disease control Recruiting nowThis is the first study in people to test a new oral drug called SW-682. It aims to find a safe and effective dose for adults with advanced solid tumors that have stopped responding to other treatments. The study will focus on patients whose tumors have specific genetic changes i…
Matched conditions: MESOTHELIOMA, MALIGNANT
Phase: PHASE1 • Sponsor: SpringWorks Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Smart cell therapy aims to target advanced cancers while sparing healthy tissue
Disease control Recruiting nowThis study is testing a new type of personalized cell therapy for adults with advanced solid tumors that have come back or spread. The therapy, called Tmod CAR T, is designed to recognize and kill cancer cells while using a built-in safety switch to protect the patient's healthy …
Matched conditions: MESOTHELIOMA, MALIGNANT
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC
-
New surgical hope for inoperable lung cancer patients
Symptom relief Recruiting nowThis study is testing whether a surgery to remove part of the lung lining can help reduce symptoms and improve quality of life for people with advanced pleural mesothelioma that cannot be fully removed. Researchers will follow 30 participants for about 2 years after surgery to tr…
Matched conditions: MESOTHELIOMA, MALIGNANT
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Mar 23, 2026 15:15 UTC
-
Scientists collect cancer patients' cells for future 'living drug' therapy
Knowledge-focused Recruiting nowThis study aims to collect tumor tissue and blood cells from people with advanced solid tumors to prepare for future CAR T-cell therapy. Researchers will analyze the cancer tissue to understand how tumors hide from the immune system and collect participants' own immune cells thro…
Matched conditions: MESOTHELIOMA, MALIGNANT
Sponsor: A2 Biotherapeutics Inc. • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:55 UTC